Literature DB >> 31935054

Tutuilamides A-C: Vinyl-Chloride-Containing Cyclodepsipeptides from Marine Cyanobacteria with Potent Elastase Inhibitory Properties.

Lena Keller1, Kirley Marques Canuto1,2, Chenxi Liu3, Brian M Suzuki3, Jehad Almaliti1,4, Asfandyar Sikandar5, C Benjamin Naman1,6, Evgenia Glukhov1, Danmeng Luo7, Brendan M Duggan3, Hendrik Luesch7, Jesko Koehnke5, Anthony J O'Donoghue3, William H Gerwick1,3.   

Abstract

Marine cyanobacteria (blue-green algae) have been shown to possess an enormous capacity to produce structurally diverse natural products that exhibit a broad spectrum of potent biological activities, including cytotoxic, antifungal, antiparasitic, antiviral, and antibacterial activities. Using mass-spectrometry-guided fractionation together with molecular networking, cyanobacterial field collections from American Samoa and Palmyra Atoll yielded three new cyclic peptides, tutuilamides A-C. Their structures were established by spectroscopic techniques including 1D and 2D NMR, HR-MS, and chemical derivatization. Structure elucidation was facilitated by employing advanced NMR techniques including nonuniform sampling in combination with the 1,1-ADEQUATE experiment. These cyclic peptides are characterized by the presence of several unusual residues including 3-amino-6-hydroxy-2-piperidone and 2-amino-2-butenoic acid, together with a novel vinyl chloride-containing residue. Tutuilamides A-C show potent elastase inhibitory activity together with moderate potency in H-460 lung cancer cell cytotoxicity assays. The binding mode to elastase was analyzed by X-ray crystallography revealing a reversible binding mode similar to the natural product lyngbyastatin 7. The presence of an additional hydrogen bond with the amino acid backbone of the flexible side chain of tutuilamide A, compared to lyngbyastatin 7, facilitates its stabilization in the elastase binding pocket and possibly explains its enhanced inhibitory potency.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31935054      PMCID: PMC7480958          DOI: 10.1021/acschembio.9b00992

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  21 in total

1.  Binding structure of elastase inhibitor scyptolin A.

Authors:  Ute Matern; Christian Schleberger; Stjepan Jelakovic; Jürgen Weckesser; Georg E Schulz
Journal:  Chem Biol       Date:  2003-10

2.  Lyngbyastatin 4, a dolastatin 13 analogue with elastase and chymotrypsin inhibitory activity from the marine cyanobacterium Lyngbya confervoides.

Authors:  Susan Matthew; Cliff Ross; James R Rocca; Valerie J Paul; Hendrik Luesch
Journal:  J Nat Prod       Date:  2007-01       Impact factor: 4.050

Review 3.  Subtilases: the superfamily of subtilisin-like serine proteases.

Authors:  R J Siezen; J A Leunissen
Journal:  Protein Sci       Date:  1997-03       Impact factor: 6.725

4.  Symplostatin 2: a dolastatin 13 analogue from the marine cyanobacterium Symploca hydnoides.

Authors:  G G Harrigan; H Luesch; W Y Yoshida; R E Moore; D G Nagle; V J Paul
Journal:  J Nat Prod       Date:  1999-04       Impact factor: 4.050

5.  LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions.

Authors:  A C Wallace; R A Laskowski; J M Thornton
Journal:  Protein Eng       Date:  1995-02

6.  Molassamide, a depsipeptide serine protease inhibitor from the marine cyanobacterium Dichothrix utahensis.

Authors:  Sarath P Gunasekera; Margaret W Miller; Jason C Kwan; Hendrik Luesch; Valerie J Paul
Journal:  J Nat Prod       Date:  2010-03-26       Impact factor: 4.050

Review 7.  From dolastatin 13 to cyanopeptolins, micropeptins, and lyngbyastatins: the chemical biology of Ahp-cyclodepsipeptides.

Authors:  Steffen Köcher; Sarah Resch; Till Kessenbrock; Lukas Schrapp; Michael Ehrmann; Markus Kaiser
Journal:  Nat Prod Rep       Date:  2020-02-26       Impact factor: 13.423

8.  PHENIX: a comprehensive Python-based system for macromolecular structure solution.

Authors:  Paul D Adams; Pavel V Afonine; Gábor Bunkóczi; Vincent B Chen; Ian W Davis; Nathaniel Echols; Jeffrey J Headd; Li-Wei Hung; Gary J Kapral; Ralf W Grosse-Kunstleve; Airlie J McCoy; Nigel W Moriarty; Robert Oeffner; Randy J Read; David C Richardson; Jane S Richardson; Thomas C Terwilliger; Peter H Zwart
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-01-22

9.  Metamorphic enzyme assembly in polyketide diversification.

Authors:  Liangcai Gu; Bo Wang; Amol Kulkarni; Todd W Geders; Rashel V Grindberg; Lena Gerwick; Kristina Håkansson; Peter Wipf; Janet L Smith; William H Gerwick; David H Sherman
Journal:  Nature       Date:  2009-06-04       Impact factor: 49.962

Review 10.  "Head-to-side-chain" cyclodepsipeptides of marine origin.

Authors:  Marta Pelay-Gimeno; Judit Tulla-Puche; Fernando Albericio
Journal:  Mar Drugs       Date:  2013-05-21       Impact factor: 5.118

View more
  10 in total

Review 1.  Cyanobacterial secondary metabolites towards improved commercial significance through multiomics approaches.

Authors:  Shaloo Verma; Shobit Thapa; Nahid Siddiqui; Hillol Chakdar
Journal:  World J Microbiol Biotechnol       Date:  2022-04-29       Impact factor: 3.312

2.  Preparation, identification, and molecular docking of novel elastase inhibitory peptide from walnut (Juglans regia L.) meal.

Authors:  Yu Xiong; Peng Peng; Shi-Jia Chen; Min Chang; Qian Wang; Sheng-Nan Yin; Di-Feng Ren
Journal:  Food Chem (Oxf)       Date:  2022-10-03

Review 3.  Targeting eukaryotic proteases for natural products-based drug development.

Authors:  Fatma H Al-Awadhi; Hendrik Luesch
Journal:  Nat Prod Rep       Date:  2020-06-24       Impact factor: 13.423

4.  Exploring the Chemical Space of Macro- and Micro-Algae Using Comparative Metabolomics.

Authors:  Alison H Hughes; Florent Magot; Ahmed F Tawfike; Cecilia Rad-Menéndez; Naomi Thomas; Louise C Young; Laura Stucchi; Daniele Carettoni; Michele S Stanley; RuAngelie Edrada-Ebel; Katherine R Duncan
Journal:  Microorganisms       Date:  2021-02-03

Review 5.  Cyanobacteria as Natural Therapeutics and Pharmaceutical Potential: Role in Antitumor Activity and as Nanovectors.

Authors:  Hina Qamar; Kashif Hussain; Aishwarya Soni; Anish Khan; Touseef Hussain; Benoît Chénais
Journal:  Molecules       Date:  2021-01-05       Impact factor: 4.411

6.  Native metabolomics identifies the rivulariapeptolide family of protease inhibitors.

Authors:  Raphael Reher; Allegra T Aron; Pavla Fajtová; Paolo Stincone; Berenike Wagner; Alicia I Pérez-Lorente; Chenxi Liu; Ido Y Ben Shalom; Wout Bittremieux; Mingxun Wang; Kyowon Jeong; Marie L Matos-Hernandez; Kelsey L Alexander; Eduardo J Caro-Diaz; C Benjamin Naman; J H William Scanlan; Phil M M Hochban; Wibke E Diederich; Carlos Molina-Santiago; Diego Romero; Khaled A Selim; Peter Sass; Heike Brötz-Oesterhelt; Chambers C Hughes; Pieter C Dorrestein; Anthony J O'Donoghue; William H Gerwick; Daniel Petras
Journal:  Nat Commun       Date:  2022-08-08       Impact factor: 17.694

Review 7.  Marine Cyanobacteria: A Source of Lead Compounds and their Clinically-Relevant Molecular Targets.

Authors:  Lik Tong Tan; Ma Yadanar Phyo
Journal:  Molecules       Date:  2020-05-08       Impact factor: 4.411

8.  Cyanobacteria Secondary Metabolites as Biotechnological Ingredients in Natural Anti-Aging Cosmetics: Potential to Overcome Hyperpigmentation, Loss of Skin Density and UV Radiation-Deleterious Effects.

Authors:  Rita Favas; Janaína Morone; Rosário Martins; Vitor Vasconcelos; Graciliana Lopes
Journal:  Mar Drugs       Date:  2022-03-01       Impact factor: 5.118

Review 9.  Peptide Human Neutrophil Elastase Inhibitors from Natural Sources: An Overview.

Authors:  Lorenza Marinaccio; Azzurra Stefanucci; Giuseppe Scioli; Alice Della Valle; Gokhan Zengin; Angelo Cichelli; Adriano Mollica
Journal:  Int J Mol Sci       Date:  2022-03-08       Impact factor: 5.923

10.  New Micropeptins with Anti-Neuroinflammatory Activity Isolated from a Cyanobacterial Bloom.

Authors:  Riley D Kirk; Haiyin He; Paul G Wahome; ShiBiao Wu; Guy T Carter; Matthew J Bertin
Journal:  ACS Omega       Date:  2021-06-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.